Spinal Elements earns FDA clearance for titanium surface coating

Written by Shayna Korol | November 08, 2018 | Print  |

Spinal Elements received FDA clearance for claims related to its Ti-Bond titanium surface coating technology.

The company's portfolio includes several PEEK interbody fusion products featuring Ti-Bond, including the recently introduced Lucent XP height- and lordosis-expandable interbody device.

"Spinal Elements has had a long, successful experience with the clinical application of Ti-Bond technology in the spine," said Jason Blain, president and CEO of Spinal Elements. "This FDA clearance represents an important scientific element of the overall Ti-Bond story — one that will expand even more as the platform continues to flourish and we provide an increasing number of technology-based solutions to improve patient outcomes."

More articles on surface technology:
Titan Spine completes funding round: 3 things to know
Additive manufacturing company introduces new 3D-printed PEEK application — 3 things to know
FDA clears Zimmer Biomet's patient-specific revision knee system

© Copyright ASC COMMUNICATIONS 2018. Interested in LINKING to or REPRINTING this content? View our policies here.